Incyte Corp (0J9P)
LSE
Incyte Corp and Novartis AG on Monday said a phase 3 study of ruxolitinib in Covid-19 patients failed to meet its pri ...
The following is a round-up of updates by global companies, issued on Thursday and Friday and not separately reported ...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 66.79 | 66.79 | 66.79 | 2548 | 66.79 | DE |
4 | 0 | 0 | 66.79 | 66.79 | 66.79 | 5054 | 66.79 | DE |
12 | 0 | 0 | 66.79 | 66.79 | 66.79 | 2340 | 66.79 | DE |
26 | 0 | 0 | 66.79 | 66.79 | 66.79 | 1646 | 66.79 | DE |
52 | 0 | 0 | 66.79 | 66.79 | 66.79 | 1873 | 66.79 | DE |
156 | 0 | 0 | 66.79 | 66.79 | 66.79 | 5223 | 66.79 | DE |
260 | 0 | 0 | 66.79 | 66.79 | 66.79 | 4301 | 66.79 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.